Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled pen (382593)

ARTG ID

382593

ARTG Name

DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled pen

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

June 3, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sanofi-Aventis Australia Pty Ltd

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01171-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01199-1

Active Ingredients

Ingredient Name

dupilumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy